Fig. 2From: A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritisMean change (± SD) from baseline to week 12 in WOMAC total, WOMAC pain, WOMAC stiffness, WOMAC physical function and Subject Global Assessment in men. P values refer to differences between placebo and choline-stabilized orthosilicic acid (ch-OSA)Back to article page